+

WO2001006005A3 - Methode diagnostique - Google Patents

Methode diagnostique Download PDF

Info

Publication number
WO2001006005A3
WO2001006005A3 PCT/GB2000/002741 GB0002741W WO0106005A3 WO 2001006005 A3 WO2001006005 A3 WO 2001006005A3 GB 0002741 W GB0002741 W GB 0002741W WO 0106005 A3 WO0106005 A3 WO 0106005A3
Authority
WO
WIPO (PCT)
Prior art keywords
sequences
diagnostic method
cancer
long term
term prognosis
Prior art date
Application number
PCT/GB2000/002741
Other languages
English (en)
Other versions
WO2001006005A2 (fr
Inventor
Karim Malik
Keith Brown
Original Assignee
Univ Bristol
Karim Malik
Keith Brown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9916669.6A external-priority patent/GB9916669D0/en
Priority claimed from GBGB9926293.3A external-priority patent/GB9926293D0/en
Application filed by Univ Bristol, Karim Malik, Keith Brown filed Critical Univ Bristol
Priority to EP20000946122 priority Critical patent/EP1200623A2/fr
Priority to JP2001511214A priority patent/JP2003505035A/ja
Priority to AU60006/00A priority patent/AU6000600A/en
Publication of WO2001006005A2 publication Critical patent/WO2001006005A2/fr
Publication of WO2001006005A3 publication Critical patent/WO2001006005A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une méthode permettant de détecter un cancer chez un individu par la détection d'une modification de son empreinte génomique, ainsi qu'une méthode permettant de déterminer le pronostic à long terme d'un sujet chez lequel on a diagnostiqué un cancer, sur la base des changements des états de méthylation d'une séquence nucléotidique spécifique.
PCT/GB2000/002741 1999-07-15 2000-07-17 Methode diagnostique WO2001006005A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP20000946122 EP1200623A2 (fr) 1999-07-15 2000-07-17 Methode diagnostique
JP2001511214A JP2003505035A (ja) 1999-07-15 2000-07-17 診断方法
AU60006/00A AU6000600A (en) 1999-07-15 2000-07-17 Diagnostic method

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9916669.6 1999-07-15
GBGB9916669.6A GB9916669D0 (en) 1999-07-15 1999-07-15 Diagnostic method
GB9926293.3 1999-11-05
GBGB9926293.3A GB9926293D0 (en) 1999-11-05 1999-11-05 Diagnostic method

Publications (2)

Publication Number Publication Date
WO2001006005A2 WO2001006005A2 (fr) 2001-01-25
WO2001006005A3 true WO2001006005A3 (fr) 2001-05-25

Family

ID=26315771

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/002741 WO2001006005A2 (fr) 1999-07-15 2000-07-17 Methode diagnostique

Country Status (4)

Country Link
EP (1) EP1200623A2 (fr)
JP (1) JP2003505035A (fr)
AU (1) AU6000600A (fr)
WO (1) WO2001006005A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2421102A1 (fr) 2000-08-25 2002-03-07 Lovelace Respiratory Research Institute Methode de detection de cancer par reaction de polymerisation en chaine specifique de la methylation imbriquee
WO2003062441A1 (fr) * 2002-01-18 2003-07-31 Genzyme Corporation Procedes de detection d'adn foetal et de quantification d'alleles
GB0209776D0 (en) * 2002-04-29 2002-06-05 Univ Bristol Diagnostic method
FR2854903A1 (fr) * 2003-05-13 2004-11-19 Centre Nat Rech Scient Utilisation des loci bage (b melanoma antigens) comme marqueurs tumoraux
WO2016041010A1 (fr) 2014-09-15 2016-03-24 Garvan Institute Of Medical Research Méthodes pour le diagnostic, le pronostic et la surveillance du cancer du sein et réactifs correspondants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350840A (en) * 1989-11-13 1994-09-27 Massachusetts Institute Of Technology Localization and characterization of the Wilms' tumor gene
WO1999001580A1 (fr) * 1997-07-03 1999-01-14 Case Western Reserve University Compositions et procedes de detection de dysfonctionnements d'empreinte genomique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350840A (en) * 1989-11-13 1994-09-27 Massachusetts Institute Of Technology Localization and characterization of the Wilms' tumor gene
WO1999001580A1 (fr) * 1997-07-03 1999-01-14 Case Western Reserve University Compositions et procedes de detection de dysfonctionnements d'empreinte genomique

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
CAMPBELL C E ET AL.: "Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus", ONCOGENE, vol. 9, 1994, pages 583 - 595, XP000981271 *
FEINBERG A P: "Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction", CANCER RESEARCH, vol. 59, 1999, pages 1743s - 1746s, XP002161164 *
GESSLER M AND BRUNS G A P: "Sequence of the WT1 upstream region including the Wit-1 gene", GENOMICS, vol. 17, 1993, pages 499 - 501, XP000981270 *
HILTUNEN M O ET AL.: "Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer", BRITISH JOURNAL OF CANCER, vol. 76, no. 9, 1997, pages 1124 - 1130, XP000979772 *
HUANG T H-M ET AL.: "Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique", CANCER RESEARCH, vol. 57, 1997, pages 1030 - 1034, XP002161163 *
LAUX D E ET AL.: "Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, vol. 38, 1997, pages A1195, XP000979879 *
MALIK K ET AL.: "Identification and differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor", CANCER RESEARCH, vol. 60, 2000, pages 2356 - 2360, XP002161165 *
MALIK K T A ET AL: "IDENTIFICATION OF AN ANTISENSE WT1 PROMOTER IN INTRON 1: IMPLICATIONS FOR WT1 REGULATION", ONCOGENE,GB,BASINGSTOKE, HANTS, vol. 11, 1995, pages 1589 - 1595, XP002910386, ISSN: 0950-9232 *
MOORWOOD K ET AL.: "Antisense WT1 transcription paralleles sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro", JOURNAL OF PATHOLOGY, vol. 185, 1998, pages 352 - 359, XP000981275 *
MOORWOOD K ET AL.: "Definition of a novel negative regulatory element of the WT1 antisense promotor", ANTICANCER RESEARCH, vol. 18, no. 6C, 1998, pages 4909 - 4910, XP000979768 *
MOULTON T ET AL.: "Genomic imprinting and Wilms' tumor", MEDICAL AND PEDIATRIC ONCOLOGY, vol. 27, 1996, pages 476 - 483, XP000979774 *
TYCKO B: "DNA METHYLATION IN GENOMIC IMPRINTING", MUTATION RESEARCH,NL,AMSTERDAM, vol. 386, no. 2, 1997, pages 131 - 140, XP002070305, ISSN: 0027-5107 *

Also Published As

Publication number Publication date
EP1200623A2 (fr) 2002-05-02
WO2001006005A2 (fr) 2001-01-25
AU6000600A (en) 2001-02-05
JP2003505035A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
WO2002000927A3 (fr) Diagnostic de troubles lies a des genes de developpement
WO2004013357A3 (fr) Sequences nucleotidiques specifiques a francisella tularensis et methodes de detection de francisella tularensis
WO2001077164A3 (fr) Diagnostic de maladies associees a l'apoptose
PL1633888T3 (pl) Środki i sposoby detekcji docelowych sekwencji nukleotydowych z użyciem oznaczeń ligacji i par ulepszonych sond oligonukleotydowych
WO2005047543A3 (fr) Dosage de ligation
WO2001068912A3 (fr) Diagnostic d'affections associees a des genes suppresseurs de tumeurs et a des oncogenes
WO2003064701A3 (fr) Procede d'analyse de motifs de methylation de cytosine
PT1687609E (pt) Sondas fluorescentes para a detecção de adn por hibridação com uma maior sensibilidade e menor ruído de fundo
WO2002061133A3 (fr) Detection d'acide nucleique avec des sondes structurees
WO2003025127A3 (fr) Procedes, kits et compositions d'hybridation chromogene in situ
WO2000024933A8 (fr) Detection de la perte d'heterozygosite dans les tumeurs et le serum de patients atteints de melanome
WO2002022879A3 (fr) Detection de l'instabilite des microsatellites et utilisation de celle-ci dans le diagnostic de tumeurs
WO2005001141A8 (fr) Methodes et acides nucleiques pour l'analyse de troubles de la proliferation de cellules colorectales
WO2008011620A3 (fr) Procédés et acides nucléiques destinés aux analyses de troubles associés à une prolifération cellulaire
IL132966A0 (en) Method and system for detecting oligonucleotides in a sample
WO2003014388A3 (fr) Acides nucleiques d'analyse d'un cancer du colon et procede associe
WO2001006005A3 (fr) Methode diagnostique
WO2002046454A3 (fr) Diagnostic de pathologies associees a l'angiogenese
SI1730315T1 (sl) Polimorfizmi v genu NOD2/CARD15
SG153624A1 (en) Isometric primer extension method and kit for detection and quantification of specific nucleic acid
AUPR221400A0 (en) Diagnostic assay
WO2002036814A3 (fr) Diagnostic de maladies associees au gene cdk4
WO2001044510A3 (fr) Amplification d'acides nucleiques et detection d'especes de mycobacteries
WO2000056924A3 (fr) Sequence genomique du gene $i(purh) et des marqueurs bialleliques associes au $i(purh)
WO2005001140A3 (fr) Methodes et acides nucleiques destines a analyser des troubles a evolution chronique des cellules du colon

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000946122

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000946122

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000946122

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载